Emergent BioSolutions

Activity by year

201820192020202120222023202420252026

Contract

Jul 31, 2023CONTRACTUnited States$704.0M
Emergent BioSolutions awarded $704M BARDA contract for Ebola treatment
Emergent BioSolutions Inc. was awarded a 10-year contract by BARDA valued at up to $704 million for advanced development, manufacturing scale-up, and procurement of Ebanga treatment for Ebola virus disease.
Emergent BioSolutions Biomedical Advanced Research and Development Authority customer #Medical Devices investors.emergentbiosolutions.com
Jan 6, 2023CONTRACTUnited States$379.6M
CCC awarded $379.6M U.S. DoD contract for Emergent BioSolutions' RSDL kit
Canadian Commercial Corporation (CCC) was awarded a $379.6 million contract by the U.S. Department of Defense to supply Emergent BioSolutions Canada's RSDL (Reactive Skin Decontamination Lotion Kit) for use by all branches of the U.S. military.
Canadian Commercial Corporation U.S. Department of Defense customer Emergent BioSolutions supplier #Specialty Chemicals ccc.ca
Sep 28, 2018CONTRACTBaltimore, Maryland, United States
Emergent BioSolutions extends ABEC deal for single-use system at Maryland plant
Emergent BioSolutions extended its partnership with ABEC and added a dual-purpose single-use system at its Bayview facility in Baltimore, Maryland. ABEC shipped a custom CSR dual-purpose system for microbial fermentation and mammalian cell culture.
Emergent BioSolutions customer ABEC supplier #Industrial Machinery bioprocessintl.com

Customers

Suppliers

Loading…